Live Breaking News & Updates on Pac Bio Medical Science
Stay updated with breaking news from Pac bio medical science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 44,500 shares, a growth of 18.7% from the April 15th total of 37,500 shares. Based on an average daily trading volume, of 19,200 shares, the […] ....
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 44,500 shares, an increase of 18.7% from the April 15th total of 37,500 shares. Based on an average trading volume of 19,200 […] ....
Akumin (NASDAQ:AKU – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Analyst Ratings This is a summary of recent recommendations […] ....
Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation. Earnings & Valuation This table compares Biodesix and AnPac […] ....
Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Insider & Institutional Ownership 45.8% of AnPac Bio-Medical Science […] ....